Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Sabra Health Care REIT (SBRA)

Sabra Q1 2025 net income rose to $40.3 million; 2025 guidance reiterated

Positive Impact 3 of 5 earnings Written later

Sabra Health Care REIT reported first quarter 2025 net income of $40.3 million, or $0.17 per diluted share, up from $26.3 million, or $0.11, a year earlier. Total revenues rose to $183.5 million from $166.7 million, and the company reiterated its 2025 guidance. The results show year-over-year growth in both revenue and profit, with normalized FFO per diluted share up slightly to $0.35 from $0.34.

Key points

  • Net income was $40.3 million ($0.17 per diluted share) for Q1 2025, versus $26.3 million ($0.11) in Q1 2024.
  • Total revenues were $183.5 million, versus $166.7 million in Q1 2024.
  • FFO per diluted share was $0.36, versus $0.32; normalized FFO per diluted share was $0.35, versus $0.34.
  • Board declared a quarterly cash dividend of $0.30 per share, payable May 30, 2025, to holders of record as of May 16, 2025.

The filing

CompanySabra Health Care REIT (SBRA)
Form8-K, current report
Filed with the SECMay 5, 2025, 4:05 PM ET
Accession number0001492298-25-000015

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 05, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.